Holen Sie sich die Stockscreener-App
152.37
11.14%
-19.11
Handel nachbörslich:
151.19
-1.18
-0.77%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MASI?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$171.48
Offen:
$163
24-Stunden-Volumen:
981.31K
Relative Volume:
1.91
Marktkapitalisierung:
$8.10B
Einnahmen:
$2.04B
Nettoeinkommen (Verlust:
$78.60M
KGV:
105.08
EPS:
1.45
Netto-Cashflow:
$149.60M
1W Leistung:
-9.56%
1M Leistung:
-20.07%
6M Leistung:
+15.07%
1J Leistung:
+8.34%
1-Tages-Spanne:
$151.84
$163.00
1-Wochen-Bereich:
$151.84
$171.56
52-Wochen-Spanne:
$101.61
$194.88
Masimo Corp Stock (MASI) Company Profile
Firmenname
Masimo Corp
Sektor
Branche
Telefon
949-297-7000
Adresse
52 DISCOVERY, IRVINE, CA
Vergleichen Sie MASI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
152.37 | 8.10B | 2.04B | 78.60M | 149.60M | 1.45 |
|
ABT
Abbott Laboratories
|
131.63 | 228.29B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
98.50 | 145.69B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
368.15 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
87.89 | 112.70B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.98 | 42.75B | 5.72B | 4.17B | 259.90M | 6.97 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-27 | Bestätigt | Raymond James | Outperform |
| 2024-11-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-06-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-04-15 | Hochstufung | Stifel | Hold → Buy |
| 2024-03-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | Herabstufung | Jefferies | Buy → Hold |
| 2024-01-03 | Herabstufung | Needham | Buy → Hold |
| 2023-11-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-07-18 | Herabstufung | Stifel | Buy → Hold |
| 2023-07-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-02-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-12-15 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-12-05 | Bestätigt | Needham | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-09-15 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-09-14 | Eingeleitet | Loop Capital | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-02-18 | Hochstufung | Needham | Hold → Buy |
| 2022-02-16 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-10-12 | Fortgesetzt | Raymond James | Mkt Perform |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-14 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-04-20 | Herabstufung | Needham | Buy → Hold |
| 2020-03-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-07 | Bestätigt | Needham | Buy |
| 2019-04-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-03-13 | Bestätigt | Needham | Buy |
| 2018-12-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-14 | Eingeleitet | Needham | Buy |
| 2018-03-09 | Eingeleitet | Barclays | Overweight |
| 2017-08-14 | Hochstufung | BTIG Research | Neutral → Buy |
| 2017-04-04 | Bestätigt | Wedbush | Outperform |
| 2017-03-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-02-27 | Bestätigt | Wedbush | Outperform |
| 2017-02-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2016-05-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2016-05-05 | Bestätigt | Wedbush | Outperform |
| 2016-01-06 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2015-08-05 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Masimo Corp Aktie (MASI) Neueste Nachrichten
Masimo Executives to Reveal Latest Business Strategy at Major Healthcare Conference - Stock Titan
Dexcom appoints former Masimo exec as chief commercial officer - HME News
Ex-Masimo CEO Slams Bid To DQ His Hueston Hennigan Attys - Law360
How Is The Market Feeling About Masimo? - Benzinga
Masimo Partners with March of Dimes to Help Parents with Babies in the NICU Make the Transition from Hospital to Home - Quantisnow
$1000 Invested In Masimo 15 Years Ago Would Be Worth This Much Today - Benzinga
West Vancouver Mayor Mark Sager sues clients for $1M - Business in Vancouver
3 Reasons Growth Investors Will Love Masimo (MASI) - Yahoo Finance
Masimo corp director sells $341,067 in stock By Investing.com - Investing.com Australia
Masimo corp director sells $341,067 in stock - Investing.com
Masimo Corporation: The Strong Contracting - Smartkarma
Midday Stock Roundup: Xponential Fitness Plunges 38%, GEN Restaurant Group Up 10% - Orange County Business Journal
Zacks.com featured highlights include Masimo, Robinhood Markets and Discover Financial Services - Yahoo
Charles Schwab Investment Management Inc. Boosts Position in Masimo Co. (NASDAQ:MASI) - Defense World
Masimo’s COO Muhsin Bilal sells over $5 million in stock - Investing.com India
Handheld Multi-Parameter Monitoring Devices Market Size to Cross US$ 5.3 Billion by 2035, Growing at 4.6% CAGR with Rising Demand for Portable Diagnostics – Analysis by TMR - GlobeNewswire Inc.
Masimo Founder Urges Toss Of 'Empty Voting' Suit - Law360
Apple defeats AliveCor bid to block US smartwatch imports in US appeal - Reuters.com
Bank of New York Mellon Corp Sells 4,739 Shares of Masimo Co. (NASDAQ:MASI) - Defense World
Apple Seeks Ban Against Masimo's Original Smartwatch - Law360
Masimo Corporation (MASI) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Former Masimo CEO Joe Kiani plans to sue board members - MassDevice
Joe Kiani Seeks $100M in Statutory Penalties from Masimo - Orange County Business Journal
Apple Says Masimo Kept Selling Smartwatch Despite Claims (1) - Bloomberg Law
Truist Financial Corp Decreases Holdings in Masimo Co. (NASDAQ:MASI) - Defense World
What Will Masimo Reveal at the Raymond James Conference? Key Details for Investors - StockTitan
Masimo Corp. Earnings Call Highlights Robust Growth - TipRanks
Decoding Masimo Corp (MASI): A Strategic SWOT Insight - GuruFocus.com
Masimo Corporation (NASDAQ:MASI) Q4 2024 Earnings Call Transcript - Insider Monkey
BTIG raises Masimo stock price target to $206, maintains buy By Investing.com - Investing.com South Africa
BTIG raises Masimo stock price target to $206, maintains buy - Investing.com
Principal Financial Group Inc. Buys 153 Shares of Masimo Co. (NASDAQ:MASI) - Defense World
MASI Stock Gains Following Q4 Earnings Beat, Gross Margin Contracts - Yahoo Finance
Masimo Corp (MASI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Challenges - Yahoo Finance
Masimo Corp. Reports Strong Healthcare Growth in 2024 - TipRanks
Masimo: Q4 Earnings Snapshot - The Advocate
Masimo Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Masimo Tops EPS, Revenue Expectations - sharewise
MASIMO CORP SEC 10-K Report - TradingView
Masimo (NASDAQ:MASI) Posts Better-Than-Expected Sales In Q4 - Yahoo Finance
Masimo: Q4 Earnings Snapshot -February 25, 2025 at 04:53 pm EST - Marketscreener.com
Masimo Q4 Non-GAAP Earnings, Revenue Rise; Sets Outlook -February 25, 2025 at 04:36 pm EST - Marketscreener.com
Earnings Flash (MASI) MASIMO Reports Q4 Revenue $600.7M, vs. FactSet Est of $592.6M - Marketscreener.com
Masimo Aims To DQ Hueston Hennigan As Ex-CEO's Counsel - Law360
Masimo Corporation Q4 2024 Earnings Preview - MSN
Earnings To Watch: Masimo (MASI) Reports Q4 Results Tomorrow - The Globe and Mail
Rhumbline Advisers Has $20.56 Million Holdings in Masimo Co. (NASDAQ:MASI) - MarketBeat
Unlocking Q4 Potential of Masimo (MASI): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
Masimo Corp announces bylaw amendments and shareholder rights - Investing.com
Masimo Corp announces bylaw amendments and shareholder rights By Investing.com - Investing.com South Africa
Masimo Corporation filed SEC Form 8-K: Leadership Update, Shareholder Director Nominations, Other Events, Financial Statements and Exhibits - Quantisnow
Finanzdaten der Masimo Corp-Aktie (MASI)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.71%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):